Recruiting
Phase 2

EGCG for Hepatocellular Carcinoma Chemoprevention

Sponsor:

University of Texas Southwestern Medical Center

Code:

NCT06015022

Conditions

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epigallocatechin gallate (EGCG)

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information